Workshop
EPP
1. Genetic Influences and Clinical Implications of Post-Elexacaftor/Tezacaftor/Ivacaftor Hyperbilirubinemia in Cystic Fibrosis – Presented by Charles Esther
2. Generation of KRT7-CreERT2 Ferrets for Targeting Pancreatic Duct and Acinar Cells – Presented by Xingshen Sun
3. A Multiscale Approach to Evaluate Gut Dysmotility and Gut-Neuron Axis in Cystic Fibrosis – Presented by Oscar Morales
4. Contribution of Aberrant Intestinal Mucus Properties and Epithelial Reprogramming to DIOS in CF – Presented by Camille Ehre
5. Sotagliflozin Synergizes with ETI to Ameliorate NASH-Like Pathology in Cystic Fibrosis Rabbits – Presented by Yang Liu
Aliye Uc, MD
University of Iowa Health Care
Senthilkumar Sankararaman
Cleveland Clinic Children's Hospital
Charles R. Esther, Jr., Jr., MD, PhD
University of North Carolina at Chapel Hill
Xingshen Sun
The University of Alabama at Birmingham
Oscar O. Morales, MSc
University of Saskatchewan
Camille Ehre
UNC Chapel Hill School of Medicine
Yang Liu, PhD
University of Michigan